Merck & Co., Inc. is 136.0x more valuable than PHIBRO ANIMAL HEALTH CORP by market capitalization ($294.13 B vs $2.16 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PAHC | MRK |
|---|---|---|
| Market cap | $2.16 B | $294.13 B |
| US-listed rank | #2045 | #44 |
| Revenue (latest FY) | $1.30B | $65.01B |
| Net income (latest FY) | $48.26M | $18.25B |
| Net margin | 3.7% | 28.1% |
| P/E (trailing FY) | 44.8 | 16.1 |
| SEC filings | 733 | 996 |
Merck & Co., Inc. is 136.0x more valuable than PHIBRO ANIMAL HEALTH CORP by market capitalization ($294.13 B vs $2.16 B).
In their latest fiscal years, PHIBRO ANIMAL HEALTH CORP reported $1.30B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: PHIBRO ANIMAL HEALTH CORP and Merck & Co., Inc., or browse the full rankings.